Psoriatic Arthritis
News
Psoriasis tied to abdominal aortic aneurysm in nationwide study
Key clinical point: Psoriasis predicted abdominal aortic aneurysm in a large, population-based study. Major finding: The adjusted risk of...
News
Inflectra becomes first FDA-approved biosimilar for inflammatory diseases
Conference Coverage
Severe psoriasis, kidney disease linked
Key clinical point: Severe psoriasis appears to increase the risk of both immunoglobulin A glomerulonephritis and glomerular disease. Major...
Conference Coverage
How to beat apremilast-induced diarrhea
Conference Coverage
How to beat apremilast-induced diarrhea
News
Ixekizumab approved for plaque psoriasis
News
Sparse, poor evidence supports fumarates for psoriasis
Only sparse, low-quality evidence supports using fumaric acid esters as a treatment for psoriasis.
Conference Coverage
Fresh evidence of methotrexate efficacy in psoriatic arthritis
The first-ever trial set up to test the hypothesis that a tumor necrosis factor inhibitor plus methotrexate have synergistic efficacy in psoriatic...
News
Don’t overlook topical tazarotene for psoriasis
Retinoid + superpotent steroid combined lotion is now in a phase III trial.
Conference Coverage
60 weeks of ixekizumab effective, well tolerated in moderate-to-severe plaque psoriasis
After 60 weeks of continuous ixekizumab therapy, patients with moderate-to-severe plaque psoriasis had PASI 75 scores of 87%.
News
Minimal disease activity criteria in PsA fall short
The minimal disease activity criteria used to identify low disease activity in psoriatic arthritis (PsA) may not be useful as a treatment target...